×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KTTA – pasithea therapeutics corp. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KTTA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
07:00 am
ktta
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock
Medium
Report
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock
11/28
09:20 am
ktta
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
High
Report
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
11/25
07:00 am
ktta
Pasithea Therapeutics Announces $1 Million Award by ALS Association to Study the Efficacy, Safety, and Tolerability of PAS-004 for Treatment of ALS
High
Report
Pasithea Therapeutics Announces $1 Million Award by ALS Association to Study the Efficacy, Safety, and Tolerability of PAS-004 for Treatment of ALS
11/24
07:00 am
ktta
Pasithea Therapeutics Announces Completion of Cohort 7 in Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients, with Positive Safety, Pharmacokinetic (PK), and Pharmacodynamic (PD) Data
High
Report
Pasithea Therapeutics Announces Completion of Cohort 7 in Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients, with Positive Safety, Pharmacokinetic (PK), and Pharmacodynamic (PD) Data
11/21
12:35 pm
ktta
Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients
High
Report
Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients
11/20
04:01 pm
ktta
Pasithea Therapeutics Announces Positive Phase 1 Data Including Partial Response, Demonstrating Monotherapy Clinical Activity and Favorable Safety Profile for PAS-004 in Advanced Cancer Study
High
Report
Pasithea Therapeutics Announces Positive Phase 1 Data Including Partial Response, Demonstrating Monotherapy Clinical Activity and Favorable Safety Profile for PAS-004 in Advanced Cancer Study
11/18
01:18 pm
ktta
Pasithea Therapeutics (NASDAQ:KTTA) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Pasithea Therapeutics (NASDAQ:KTTA) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
11/7
01:14 am
ktta
Pasithea Therapeutics (NASDAQ:KTTA) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Pasithea Therapeutics (NASDAQ:KTTA) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/2
09:24 am
ktta
Form 8-K Pasithea Therapeutics For: Nov 28
Low
Report
Form 8-K Pasithea Therapeutics For: Nov 28
12/1
09:07 am
ktta
Form 4 Pasithea Therapeutics For: Nov 28 Filed by: STEINMAN LAWRENCE
High
Report
Form 4 Pasithea Therapeutics For: Nov 28 Filed by: STEINMAN LAWRENCE
12/1
09:04 am
ktta
Form 4 Pasithea Therapeutics For: Nov 28 Filed by: Schneiderman Daniel H
High
Report
Form 4 Pasithea Therapeutics For: Nov 28 Filed by: Schneiderman Daniel H
12/1
08:57 am
ktta
Form 4 Pasithea Therapeutics For: Nov 28 Filed by: Marques Tiago
High
Report
Form 4 Pasithea Therapeutics For: Nov 28 Filed by: Marques Tiago
12/1
08:54 am
ktta
Form 4 Pasithea Therapeutics For: Nov 28 Filed by: Dumesnil Simon
High
Report
Form 4 Pasithea Therapeutics For: Nov 28 Filed by: Dumesnil Simon
12/1
08:51 am
ktta
Form 4 Pasithea Therapeutics For: Nov 28 Filed by: Leahy Emer
Medium
Report
Form 4 Pasithea Therapeutics For: Nov 28 Filed by: Leahy Emer
12/1
08:32 am
ktta
Form 424B4 Pasithea Therapeutics
Medium
Report
Form 424B4 Pasithea Therapeutics
12/1
06:05 am
ktta
Form EFFECT Pasithea Therapeutics
Medium
Report
Form EFFECT Pasithea Therapeutics
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: